Atlas Trials

Trial to Assess the Efficacy of Midostaurin (PKC412) in Patients With c-KIT or FLT3-ITD Mutated t(8;21) AML

Clinical trial NCT01830361 · COMPLETED

Trial details

NCT number
NCT01830361
Sponsor
Technische Universität Dresden
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2013-03-13
Primary completion
2019-10-30
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.